Skip to main content
. 2020 Jun 24;6:GO.20.00032. doi: 10.1200/GO.20.00032

FIG 2.

FIG 2

Overall survival (OS) after first-line therapy. BR, bendamustine + rituximab; Clb, chlorambucil; P, prednisolone.